390 related articles for article (PubMed ID: 24517155)
1. Continuous subcutaneous hydrocortisone infusion versus oral hydrocortisone replacement for treatment of addison's disease: a randomized clinical trial.
Oksnes M; Björnsdottir S; Isaksson M; Methlie P; Carlsen S; Nilsen RM; Broman JE; Triebner K; Kämpe O; Hulting AL; Bensing S; Husebye ES; Løvås K
J Clin Endocrinol Metab; 2014 May; 99(5):1665-74. PubMed ID: 24517155
[TBL] [Abstract][Full Text] [Related]
2. Circadian hormone profiles and insulin sensitivity in patients with Addison's disease: a comparison of continuous subcutaneous hydrocortisone infusion with conventional glucocorticoid replacement therapy.
Björnsdottir S; Øksnes M; Isaksson M; Methlie P; Nilsen RM; Hustad S; Kämpe O; Hulting AL; Husebye ES; Løvås K; Nyström T; Bensing S
Clin Endocrinol (Oxf); 2015 Jul; 83(1):28-35. PubMed ID: 25400085
[TBL] [Abstract][Full Text] [Related]
3. Continuous subcutaneous hydrocortisone infusion therapy in Addison's disease: a randomized, placebo-controlled clinical trial.
Gagliardi L; Nenke MA; Thynne TR; von der Borch J; Rankin WA; Henley DE; Sorbello J; Inder WJ; Torpy DJ
J Clin Endocrinol Metab; 2014 Nov; 99(11):4149-57. PubMed ID: 25127090
[TBL] [Abstract][Full Text] [Related]
4. A Phase 2 Study of Continuous Subcutaneous Hydrocortisone Infusion in Adults With Congenital Adrenal Hyperplasia.
Nella AA; Mallappa A; Perritt AF; Gounden V; Kumar P; Sinaii N; Daley LA; Ling A; Liu CY; Soldin SJ; Merke DP
J Clin Endocrinol Metab; 2016 Dec; 101(12):4690-4698. PubMed ID: 27680873
[TBL] [Abstract][Full Text] [Related]
5. Continuous subcutaneous hydrocortisone infusion in Addison's disease.
Løvås K; Husebye ES
Eur J Endocrinol; 2007 Jul; 157(1):109-12. PubMed ID: 17609409
[TBL] [Abstract][Full Text] [Related]
6. Current and emerging therapies for Addison's disease.
Napier C; Pearce SH
Curr Opin Endocrinol Diabetes Obes; 2014 Jun; 21(3):147-53. PubMed ID: 24755997
[TBL] [Abstract][Full Text] [Related]
7. Improvement of anthropometric and metabolic parameters, and quality of life following treatment with dual-release hydrocortisone in patients with Addison's disease.
Giordano R; Guaraldi F; Marinazzo E; Fumarola F; Rampino A; Berardelli R; Karamouzis I; Lucchiari M; Manetta T; Mengozzi G; Arvat E; Ghigo E
Endocrine; 2016 Feb; 51(2):360-8. PubMed ID: 26184416
[TBL] [Abstract][Full Text] [Related]
8. Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia.
Merza Z; Rostami-Hodjegan A; Memmott A; Doane A; Ibbotson V; Newell-Price J; Tucker GT; Ross RJ
Clin Endocrinol (Oxf); 2006 Jul; 65(1):45-50. PubMed ID: 16817818
[TBL] [Abstract][Full Text] [Related]
9. A randomized, double-blind, crossover study comparing two- and four-dose hydrocortisone regimen with regard to quality of life, cortisol and ACTH profiles in patients with primary adrenal insufficiency.
Ekman B; Bachrach-Lindström M; Lindström T; Wahlberg J; Blomgren J; Arnqvist HJ
Clin Endocrinol (Oxf); 2012 Jul; 77(1):18-25. PubMed ID: 22288685
[TBL] [Abstract][Full Text] [Related]
10. Salivary cortisol day curves in assessing glucocorticoid replacement therapy in Addison's disease.
Smans L; Lentjes E; Hermus A; Zelissen P
Hormones (Athens); 2013; 12(1):93-100. PubMed ID: 23624135
[TBL] [Abstract][Full Text] [Related]
11. Conventional glucocorticoid replacement overtreats adult hypopituitary patients with partial ACTH deficiency.
Agha A; Liew A; Finucane F; Baker L; O'Kelly P; Tormey W; Thompson CJ
Clin Endocrinol (Oxf); 2004 Jun; 60(6):688-93. PubMed ID: 15163331
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoid replacement is permissive for rapid eye movement sleep and sleep consolidation in patients with adrenal insufficiency.
García-Borreguero D; Wehr TA; Larrosa O; Granizo JJ; Hardwick D; Chrousos GP; Friedman TC
J Clin Endocrinol Metab; 2000 Nov; 85(11):4201-6. PubMed ID: 11095454
[TBL] [Abstract][Full Text] [Related]
13. Acutely raised corticotropin levels in Addison's disease are not associated with increased plasma arginine vasopressin and corticotropin-releasing factor concentrations in peripheral plasma.
Wittert GA; Livesey JH; Florkowski C; Or HK; Donald RA; Espiner EA
J Clin Endocrinol Metab; 1993 Jan; 76(1):192-6. PubMed ID: 8380605
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of two replacement regimens in primary adrenal insufficiency patients. effect on clinical symptoms, health-related quality of life and biochemical parameters.
Alonso N; Granada ML; Lucas A; Salinas I; Reverter J; Oriol A; Sanmarti A
J Endocrinol Invest; 2004 May; 27(5):449-54. PubMed ID: 15279078
[TBL] [Abstract][Full Text] [Related]
15. Salivary cortisol day curves in Addison's disease in patients on hydrocortisone replacement.
Ross IL; Levitt NS; Van der Walt JS; Schatz DA; Johannsson G; Haarburger DH; Pillay TS
Horm Metab Res; 2013 Jan; 45(1):62-8. PubMed ID: 22893258
[TBL] [Abstract][Full Text] [Related]
16. Pulsatile Subcutaneous Hydrocortisone Replacement in Primary Adrenal Insufficiency.
Simunkova K; Løvås K; Methlie P; Jovanovic N; Bifulco E; Bronstad I; Lightman SL; Husebye ES; Oksnes M
Horm Metab Res; 2023 Jul; 55(7):471-478. PubMed ID: 37172949
[TBL] [Abstract][Full Text] [Related]
17. Response to low-dose pulsatile cortisol in Addison's disease with suspected corticotropinoma.
Carr DB; Fisher JE; Rosenblatt M
Horm Metab Res; 1986 Aug; 18(8):569-73. PubMed ID: 3019857
[TBL] [Abstract][Full Text] [Related]
18. Pulsatile thyrotropin secretion in patients with Addison's disease during variable glucocorticoid therapy.
Hangaard J; Andersen M; Grodum E; Koldkjaer O; Hagen C
J Clin Endocrinol Metab; 1996 Jul; 81(7):2502-7. PubMed ID: 8675567
[TBL] [Abstract][Full Text] [Related]
19. Long-term use of continuous subcutaneous hydrocortisone infusion therapy in patients with congenital adrenal hyperplasia.
Mallappa A; Nella AA; Sinaii N; Rao H; Gounden V; Perritt AF; Kumar P; Ling A; Liu CY; Soldin SJ; Merke DP
Clin Endocrinol (Oxf); 2018 Oct; 89(4):399-407. PubMed ID: 30003563
[TBL] [Abstract][Full Text] [Related]
20. [Metabolic assessment of hydrocortisone replacement therapy in patients with primary adrenocortical insufficiency].
Fichna M; Gryczyńska M; Sowińska A; Sowiński J
Przegl Lek; 2011; 68(2):96-102. PubMed ID: 21751518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
